74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Masimo Corp
Closed
SectorHealthcare
162.9 3.1
Overview
Share price change
24h
Min
155.38
Max
163.69
Income | -359M -350M |
|---|---|
Sales | 96M 601M |
P/E Sector Avg | 118.556 57.333 |
EPS | 1.8 |
Profit margin | -58.199 |
Employees | 3,600 |
EBITDA | -367M -321M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +29.17% upside |
Next Earnings | 6 May 2025 |
|---|
Market Cap | -1.2B 8.1B |
|---|---|
Previous open | 159.8 |
Previous close | 162.9 |
Technical Score
By Trading Central
Confidence
Bullish Evidence
Masimo Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Masimo Corp Forecast
Price Target
By TipRanks
29.17% upside
12 Months Forecast
Average 204 USD 29.17%
High 215 USD
Low 190 USD
Based on 5 Wall Street analysts offering 12 month price targets forMasimo Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Masimo Corp
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
